OBR Daily Commentary

forumImage

Genentech’s Shocking $2 Billion 340B Revelation

(Drug Channels) Nov 15, 2016 - ICYMI, the Roche Group recently made a startling disclosure: For the first half of 2016, the 340B Drug Pricing Program accounted for 18% of Genentech’s volume.

Read Article arrow

Jeff Patton, M.D. (Posted: November 15, 2016)

quotesGood for Genentech! The abuse of this program needs to end ASAP. I agree with the author and hope that the new administration will take a close look at this program and bring it back to the initial and laudable intent and away from current abuses.quotes

Add Comment 1 Comment
forumImage

Michael Kolodziej, M.D., a Leader in Oncology Value-based Care, Joins Flatiron Health to Lead Managed Care Strategy

(Flatiron Health) July 25, 2016 - Flatiron Health announced today that Michael Kolodziej, M.D., joined as national medical director, Managed Care Strategy. In this role, he will focus on supporting innovative alternative payment programs on behalf of community oncology providers in a number of commercial markets across the country.

Read Article arrow

Jeff Patton, M.D. (Posted: July 26, 2016)

quotesThis is great news for community oncology! Mike has had a great career as an oncology provider, practice leader and most recently the oncology medical director for a national health plan. Combining his clinical and managed care expertise with Flatiron Health's innovative technology capabilities will enable community oncology practices to bring value based care opportunities to payors across the country. Tennessee Oncology, for one, is looking forward to working with Mike and Flatiron Health to improve patient experience and outcomes while reducing the total cost of care.quotes

Add Comment 1 Comment
forumImage

Study Finds Doctors Quick To Change Practice For Breast Cancer Patients

(Kaiser Health News) July 8, 2016 - Doctors cling to comfortable, widely used medical practices, even if they’re no longer particularly effective, right? A new study disputes that popular perception.

Read Article arrow

Jeff Patton, M.D. (Posted: July 08, 2016)

quotesI'm very happy to see this publication. Those of us who practice in sophisticated medical communities know that we are quick to adjust our practice patterns based upon the latest evidence but we are certainly guilty of not publishing data to support this fact. I will be interested to see if the main stream media picks up on this publication. My prediction is no...does fit their preferred narrative.quotes

Add Comment 1 Comment

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...